๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma

โœ Scribed by Naoki Yamanaka; Eizo Okamoto; Tatsuya Ando; Takeshi Oriyama; Jiro Fujimoto; Kazutaka Furukawa; Tsuneo Tanaka; Wataru Tanaka; Takashi Nishigami


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
900 KB
Volume
76
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Background:

The mode of tumor growth of intrahepatic cholangiocarcinoma (cc) varies considerably from patient to patient. this study describes the clinicopathologic variety of the extraductal mass-forming type of cc.

Methods:

Patients with cc characterized by an extraductal mass (n = 26) who underwent hepatectomy from 1976 through 1992 were clinicopathologically classified into three types: type i (n = 7), no biliary stricture; type ii (n = 13), biliary stricture without jaundice; and type iii (n = 6), biliary stricture with jaundice.

Results:

Type i included three patients with microductular-trabecular arrangement and behavior reminiscent of hepatocellular carcinoma (high association with chronic liver disease, mild positivity for alpha-fetoprotein [afp], no lymph node metastasis, but frequent intrahepatic metastasis), in contrast to the other typical cholangiocarcinoma. hepatolithiasis was associated only with type ii cc: the serum positivity for afp and carcinoembryonic antigen was much higher in type i cc, whereas positivity of ca 19-9 was highest in type iii. involvement of the portal vein, hepatic artery, or hepatic duct was most frequent in type iii cc, which necessitated resection of the extrahepatic bile duct and hepatectomy.

Conclusion:

The clinicopathologic behavior of intrahepatic cc differs considerably according to the presence or absence of stricture of the biliary tree. thus, cc without biliary stricture behaves more like hepatocellular carcinoma, whereas cc with biliary stricture is more like hilar or extrahepatic bile duct carcinoma.


๐Ÿ“œ SIMILAR VOLUMES


MUC4 is a novel prognostic factor of int
โœ Hiroaki Shibahara; Shugo Tamada; Michiyo Higashi; Masamichi Goto; Surinder K. Ba ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 392 KB

Complete surgical resection of the tumor is the sole approach to improve the cure rate of patients with intrahepatic cholangiocarcinoma-mass forming type (ICC-MF). Although patients are treated by curative resection, many of them show poor outcome. Mucin (MUC)4 expression has been implicated as a ma